Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alexanian

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Canadian Medical Association Journal|March 6, 1971
Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyaninJ Harris, R Alexanian, E Hersh, et al.
Annals of Internal Medicine|April 1, 1989
High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myelomaB Barlogie, L Smallwood, T Smith, et al.
Leukemia & Lymphoma|September 1, 1995
VAD-cyclosporine therapy for VAD-resistant multiple myelomaD Weber, M Dimopoulos, F Sinicrope, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Blood|March 1, 1989
Plasma cell myeloma--new biological insights and advances in therapyB Barlogie, J Epstein, P Selvanayagam, et al.
Blood|September 1, 1983
Prednisone pulse therapy for refractory myelomaR Alexanian, B S Yap, G P Bodey
The International Journal of Biochemistry & Cell Biology|May 14, 2013
Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levelsArshak R Alexanian, Qing-song Liu, Zhiying Zhang
Gematologiia I Transfuziologiia|July 1, 1992
[Plasma-cell myeloma. II. New developments in the diagnosis and treatment of the disease]B Barlogie, J Epstein, P Selvanayagam, et al.
Hematology/Oncology Clinics of North America|April 1, 1992
Solitary plasmacytoma of bone and asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, K Delasalle, et al.
Arzneimittel-Forschung|December 1, 1996
Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochlorideA R Alexanian, N S Arutyunian, A A Galoyan
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Canadian Medical Association Journal|March 6, 1971
Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyaninJ Harris, R Alexanian, E Hersh, et al.
Annals of Internal Medicine|April 1, 1989
High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myelomaB Barlogie, L Smallwood, T Smith, et al.
Leukemia & Lymphoma|September 1, 1995
VAD-cyclosporine therapy for VAD-resistant multiple myelomaD Weber, M Dimopoulos, F Sinicrope, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Blood|March 1, 1989
Plasma cell myeloma--new biological insights and advances in therapyB Barlogie, J Epstein, P Selvanayagam, et al.
Blood|September 1, 1983
Prednisone pulse therapy for refractory myelomaR Alexanian, B S Yap, G P Bodey
The International Journal of Biochemistry & Cell Biology|May 14, 2013
Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levelsArshak R Alexanian, Qing-song Liu, Zhiying Zhang
Gematologiia I Transfuziologiia|July 1, 1992
[Plasma-cell myeloma. II. New developments in the diagnosis and treatment of the disease]B Barlogie, J Epstein, P Selvanayagam, et al.
Hematology/Oncology Clinics of North America|April 1, 1992
Solitary plasmacytoma of bone and asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, K Delasalle, et al.
Arzneimittel-Forschung|December 1, 1996
Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochlorideA R Alexanian, N S Arutyunian, A A Galoyan
Pageof 20